The role of lasers in modern urology

Central European Journal of Urology

Volumn 68, Issue 2, 2015, Pages 175-182

  Dołowy, Łukasz ^a   Krajewski, Wojciech ^a   Dembowski, Janusz ^a   Zdrojowy, Romuald ^a   Kołodziej, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Bladder outlet obstruction; Lasers; Urology

Indexed keywords

HEMOGLOBIN; HOLMIUM; THULIUM;

BLADDER TUMOR; BLOOD CLOTTING; COMPARATIVE EFFECTIVENESS; DIODE LASER; DISEASE ASSOCIATION; ENUCLEATION; EPIDIDYMITIS; HEALTH CARE COST; HUMAN; LASER; LASER SURGERY; LENGTH OF STAY; LITHIUM BORATE LASER; LOW LEVEL LASER THERAPY; OBSTRUCTIVE UROPATHY; PATIENT SAFETY; POTASSIUM TITANYL PHOSPHATE LASER; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REOPERATION; REVIEW; SKIN PENETRATION; THULIUM YAG LASER; TRANSURETHRAL ELECTROVAPORIZATION; TREATMENT OUTCOME; URINE RETENTION; UROLITHIASIS; UROLOGY; WATER ABSORPTION;

EID: 84931837446     PISSN: 20804806     EISSN: 20804873     Source Type: Journal    
DOI: 10.5173/ceju.2015.537     Document Type: Review

References (74)

1. Staehler G, Hofstetter A, Gorisch W, Keiditsch E, Mussiggang M. Endoscopy in experimental urology using an argon-laser beam. Endoscopy. 1976; 8: 1-4.
2. Gravas S, Bachmann A, Reich O, Roehrborn CG, Gilling PJ, De La Rosette J. Critical review of lasers in benign prostatic hyperplasia (BPH). BJU Int. 2011; 107: 1030-1043.
3. Ganesamoni R, Sabnis RB, Mishra S, et al. Prospective randomized controlled trial comparing laser lithotripsy with pneumatic lithotripsy in miniperc for renal calculi. J Endourol. 2013; 27: 1444-1449.
4. Qiu J, Teichman JM, Wang T, et al. Femtosecond laser lithotripsy: feasibility and ablation mechanism. J Biomed Opt. 2010; 15: 028001.
5. Vassar GJ, Chan KF, Teichman JM, et al. Holmium: YAG lithotripsy: photothermal mechanism. J Endourol. 1999; 13: 181-190.
6. Committee AUAPG. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol. 2003; 170: 530-547.
7. Zarrabi A, Gross AJ. The evolution of lasers in urology. Ther Adv Urol. 2011; 3: 81-89.
8. Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol. 2006; 49: 961-969.
9. Wosnitzer MS, Rutman MP. KTP/LBO laser vaporization of the prostate. Urol Clin North Am. 2009; 36: 471-483.
10. Heinrich E, Wendt-Nordahl G, Honeck P, et al. 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol. 2010; 24: 75-79.
11. Chiang PH, Chen CH, Kang CH, Chuang YC. GreenLight HPS laser 120-W versus diode laser 200-W vaporization of the prostate: comparative clinical experience. Lasers Surg Med. 2010; 42: 624-629.
12. de Lucia C, Femminella GD, Rengo G, et al. Risk of acute myocardial infarction after transurethral resection of prostate in elderly. BMC Surg. 2013; 13 Suppl 2: S35.
13. Capitan C, Blazquez C, Martin MD, Hernandez V, de la Pena E, Llorente C. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol. 2011; 60: 734-739.
14. Tugcu V, Tasci AI, Sahin S, Zorluoglu F. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol. 2008; 22: 1519-1525.
15. Madersbacher S, Lackner J, Brossner C, et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol. 2005; 47: 499-504.
16. Elshal AM, Elmansy HM, Elhilali MM. Transurethral laser surgery for benign prostate hyperplasia in octogenarians: safety and outcomes. Urology. 2013; 81: 634-639.
17. Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008; 180: 246-249.
18. Toepfer NJ, Baylor K, Henry Y, Simmons J, Berger PB. The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy. Urology. 2013; 82: 773-779.
19. Tasci AI, Tugcu V, Sahin S, Zorluoglu F. Rapid communication: photoselective vaporization of the prostate versus transurethral resection of the prostate for the large prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol. 2008; 22: 347-353.
20. Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol. 2010; 58: 349-355.
21. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol. 2006; 20: 580-585.
22. Horasanli K, Silay MS, Altay B, Tanriverdi O, Sarica K, Miroglu C. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology. 2008; 71: 247-251.
23. Skolarikos A, Papachristou C, Athanasiadis G, Chalikopoulos D, Deliveliotis C, Alivizatos G. Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol. 2008; 22: 2333-2340.
24. Telli O, Okutucu TM, Suer E, et al. A prospective, randomized comparative study of monopolar transurethral resection of the prostate versus photoselective vaporization of the prostate with GreenLight 120-W laser, in prostates less than 80 cc. Ther Adv Urol. 2015; 7: 3-8.
25. Altay B, Erkurt B, Kiremit MC, Guzelburc V, Boz MY, Albayrak S. 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci. 2015; 30: 317-323.
26. Bachmann A, Tubaro A, Barber N, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. Eur Urol. 2014; 65: 931-942.
27. Bachmann A, Tubaro A, Barber N, et al. A European Multicenter Randomized Noninferiority Trial Comparing 180 W GreenLight XPS Laser Vaporization and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: 12-Month Results of the GOLIATH Study. J Urol. 2015; 193: 570-578.
28. Elshal AM, Elkoushy MA, Elmansy HM, Sampalis J, Elhilali MM. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate. J Urol. 2014; 191: 148-154.
29. Guo S, Muller G, Bonkat, G, et al. Greenlight laser versus Diode laser vaporization of the prostate: 3-year results of a prospective non-randomized study. J Endourol. 2014.
30. Razzaghi MR, Mazloomfard MM, Mokhtarpour H, Moeini A. Diode laser (980 nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized clinical trial with 2-year follow-up. Urology. 2014; 84: 526-532.
31. Elmansy HM, Elzayat E, Elhilali MM. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial. J Urol. 2010; 184: 2023-2028.
32. Mottet N, Anidjar M, Bourdon O, et al. Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol. 1999; 13: 127-130.
33. Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol. 2004; 172: 616-619.
34. Tan A, Liao C, Mo Z, Cao Y. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg. 2007; 94: 1201-1208.
35. Gilling PJ, Aho TF, Frampton CM, King CJ, Fraundorfer MR. Holmium laser enucleation of the prostate: results at 6 years. Eur Urol. 2008; 53: 744-749.
36. Yin L, Teng J, Huang CJ, Zhang X, Xu D. Holmium laser enucleation of the prostate versus transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. J Endourol. 2013; 27: 604-611.
37. Shao Q, Zhang FB, Shang DH, Tian Y. [Comparison of holmium and thulium laser in transurethral enucleation of the prostate]. Zhonghua Nan Ke Xue. 2009; 15: 346-349.
38. Bach T, Xia SJ, Yang Y, et al. Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol. 2010; 28: 163-168.
39. Tang K, Xu Z, Xia D, et al. Early outcomes of thulium laser versus transurethral resection of the prostate for managing benign prostatic hyperplasia: a systematic review and meta-analysis of comparative studies. J Endourol. 2014; 28: 65-72.
40. Choi SW, Choi YS, Bae WJ, et al. 120 W Greenlight HPS Laser Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia in Men with Detrusor Underactivity. Korean J Urol. 2011; 52: 824-828.
41. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int. 2006; 97: 1229-1233.
42. Clemente Ramos LM. High power 980 nm diode laser: preliminary results in the treatment of benign prostatic hyperplasia. Arch Esp Urol. 2009; 62: 125-130.
43. Erol A, Cam K, Tekin A, Memik O, Coban S, Ozer Y. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol. 2009; 182: 1078-1082.
44. Rivera ME, Frank I, Viers BR, Rangel LJ, Krambeck AE. Holmium laser enucleation of the prostate and perioperative diagnosis of prostate cancer: an outcomes analysis. J Endourol. 2014; 28: 699-703.
45. Larouche A, Becker A, Schiffmann J, et al. Comparison between complication rates of laser prostatectomy electrocautery transurethral resection of the prostate: A population-based study. Can Urol Assoc J. 2014; 8: E419-424.
46. Lee WC, Lin YH, Hou CP, et al. Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males. Clin Interv Aging. 2013; 8: 1483-1488.
47. Richter T, Huebler M. Acute abdominal compartment syndrome as a complication of Holmium laser enucleation of the prostate: a case report. BMC Anesthesiol. 2014; 14: 32.
48. Breda A, Ogunyemi O, Leppert JT, Schulam PG. Flexible ureteroscopy and laser lithotripsy for multiple unilateral intrarenal stones. Eur Urol. 2009; 55: 1190-1196.
49. Herrmann TR, Liatsikos EN, Nagele U, Traxer O, Merseburger AS, European Association of U. [European Association of Urology guidelines on laser technologies]. Actas Urol Esp. 2013; 37: 63-78.
50. Adanur S, Ziypak T, Bedir F, et al. Ureteroscopy and holmium laser lithotripsy: is this procedure safe in pregnant women with ureteral stones at different locations? Arch Ital Urol Androl. 2014; 86: 86-89.
51. Chew BH, Zavaglia B, Paterson RF, et al. A multicenter comparison of the safety and effectiveness of ureteroscopic laser lithotripsy in obese and normal weight patients. J Endourol. 2013; 27: 710-714.
52. Uygun I, Okur MH, Aydogdu B, Arayici Y, Isler B, Otcu S. Efficacy and safety of endoscopic laser lithotripsy for urinary stone treatment in children. Urol Res. 2012; 40: 751-755.
53. Khoder WY, Bader M, Sroka R, Stief C, Waidelich R. Efficacy and safety of Ho:YAG laser lithotripsy for ureteroscopic removal of proximal and distal ureteral calculi. BMC Urol. 2014; 14: 62.
54. Feng C, Wu Z, Jiang H, Ding Q, Gao P. Ureteroscopic Holmium:YAG laser lithotripsy is effective for ureteral steinstrasse post-SWL. Minim Invasive Ther Allied Technol. 2013; 22: 279-282.
55. Cone EB, Eisner BH, Ursiny M, Pareek G. Cost-effectiveness comparison of renal calculi treated with ureteroscopic laser lithotripsy versus shockwave lithotripsy. J Endourol. 2014; 28: 639-643.
56. Emiliani E, Breda A. Laser endoureterotomy and endopyelotomy: an update. World J Urol. 2014; 33: 583-587.
57. Staehler G, Hofstetter A. Transurethral laser irradiation of urinary bladder tumors. Eur Urol. 1979; 5: 64-69.
58. Beer M, Jocham D, Beer A, Staehler G. Adjuvant laser treatment of bladder cancer: 8 years' experience with the Nd-YAG laser 1064 nm. Br J Urol. 1989; 63: 476-478.
59. Kramer MW, Bach T, Wolters M, et al. Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer. World J Urol. 2011; 29: 433-442.
60. Liu H, Wu J, Xue S, et al. Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer. J Int Med Res. 2013; 41: 984-992.
61. Yang D, Xue B, Zang Y, et al. Efficacy and safety of potassium-titanyl- phosphate laser vaporization for clinically non-muscle invasive bladder cancer. Urol J. 2014; 11: 1258-1263.
62. Kramer MW, Wolters M, Cash H, et al. Current evidence of transurethral Ho:YAG and Tm:YAG treatment of bladder cancer: update 2014. World J Urol. 2015; 33: 571-579.
63. Jonler M, Lund L, Bisballe S. Holmium:YAG laser vaporization of recurrent papillary tumours of the bladder under local anaesthesia. BJU Int. 2004; 94: 322-325.
64. Wolters M, Kramer MW, Becker JU, et al. Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience. World J Urol. 2011; 29: 429-432.
65. Syed HA, Talbot N, Abbas A, et al. Flexible cystoscopy and Holmium:Yttrium aluminum garnet laser ablation for recurrent nonmuscle invasive bladder carcinoma under local anesthesia. J Endourol. 2013; 27: 886-891.
66. Wong KA, Zisengwe G, Athanasiou T, O'Brien T, Thomas K. Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective? BJU Int. 2013; 112: 561-567.
67. O'Brien T, Ray E, Chatterton K, Khan MS, Chandra A, Thomas K. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer. BJU Int. 2013; 112: 1096-1104.
68. Lapini A, Minervini A, Masala A, et al. A comparison of hexaminolevulinate (Hexvix®) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study. Surg Endosc. 2012; 26: 3634-3641.
69. Kamp S, Knoll T, Osman MM, Kohrmann KU, Michel MS, Alken P. Low-power holmium:YAG laser urethrotomy for treatment of urethral strictures: functional outcome and quality of life. J Endourol. 2006; 20: 38-41.
70. Gupta NP, Ansari MS. Holmium laser core through internal urethrotomy with explantation of UroLume stent. An ideal approach for a complicated posterior urethral stricture. Int J Urol. 2004; 11: 343-344.
71. Dogra PN, Ansari MS, Gupta NP, Tandon S. Holmium laser core-through urethrotomy for traumatic obliterative strictures of urethra: initial experience. Urology. 2004; 64: 232-235.
72. Atak M, Tokgoz H, Akduman B, et al. Low-power holmium:YAG laser urethrotomy for urethral stricture disease: comparison of outcomes with the cold-knife technique. Kaohsiung J Med Sci. 2011; 27: 503-507.
73. Dutkiewicz SA, Wroblewski M. Comparison of treatment results between holmium laser endourethrotomy and optical internal urethrotomy for urethral stricture. Int Urol Nephrol. 2012; 44: 717-724.
74. Liu Q, Ma W, Li X, et al. Holmium laser endourethrotomy for the treatment of long-segment urethral strictures: a retrospective study of 190 patients. Urol J. 2014; 11: 1264-1270.